An update on community-acquired pneumonia in adults
- PMID: 11126100
- DOI: 10.1007/s12019-000-0031-8
An update on community-acquired pneumonia in adults
Abstract
Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality, despite effective therapies. Guidelines for CAP management vary widely in their approach. Resistance of S pneumoniae to penicillins and other antibiotics has prompted evaluation of the new fluoroquinolones.
Similar articles
-
Community-acquired pneumonia.Int J Clin Pract Suppl. 2000 Dec;(115):18-22. Int J Clin Pract Suppl. 2000. PMID: 11219294 Review. No abstract available.
-
A Review of the Resistance Mechanisms for β-Lactams, Macrolides and Fluoroquinolones among Streptococcus pneumoniae.Medicina (Kaunas). 2023 Oct 31;59(11):1927. doi: 10.3390/medicina59111927. Medicina (Kaunas). 2023. PMID: 38003976 Free PMC article. Review.
-
Consensus among participants for the treatment of community-acquired pneumonia: results of the postsymposium interactive question and answer session.Chemotherapy. 2000;46 Suppl 1:36-9. doi: 10.1159/000048491. Chemotherapy. 2000. PMID: 10896482 No abstract available.
-
Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment.Am J Med. 2001 Dec 17;111 Suppl 9A:4S-12S; discussion 36S-38S. doi: 10.1016/s0002-9343(01)01025-7. Am J Med. 2001. PMID: 11755437
-
Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia: analysis of a hospital claims-made database.Chest. 2003 May;123(5):1503-11. doi: 10.1378/chest.123.5.1503. Chest. 2003. PMID: 12740267
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous